Fusion Pharmaceuticals Inc (FUSN)
21.40
-0.02
(-0.09%)
USD |
NASDAQ |
Apr 29, 16:00
21.40
0.00 (0.00%)
Pre-Market: 08:15
Fusion Pharmaceuticals Shareholders Equity (Quarterly): 222.48M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 222.48M |
| September 30, 2023 | 188.47M |
| June 30, 2023 | 202.96M |
| March 31, 2023 | 200.83M |
| December 31, 2022 | 162.22M |
| September 30, 2022 | 183.14M |
| June 30, 2022 | 198.91M |
| March 31, 2022 | 215.43M |
| December 31, 2021 | 231.46M |
| Date | Value |
|---|---|
| September 30, 2021 | 246.50M |
| June 30, 2021 | 263.55M |
| March 31, 2021 | 279.07M |
| December 31, 2020 | 294.51M |
| September 30, 2020 | 306.45M |
| June 30, 2020 | 315.21M |
| March 31, 2020 | 58.34M |
| December 31, 2019 | -33.49M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-33.49M
Minimum
Dec 2019
315.21M
Maximum
Jun 2020
208.00M
Average
215.43M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 37.44B |
| Landos Biopharma Inc | 31.79M |
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 285.84M |
| Total Liabilities (Quarterly) | 63.36M |